Compound ID | 1264
Class: 2-trifluoroacetonylbenzoxazole ligand
| Spectrum of activity: | Gram-positive |
| Details of activity: | Methicillin resistant S. aureus strains. |
| Institute where first reported: | Department of Medical Microbiology and Immunobiology, University of Szeged - Faculty of Medicine, Szeged, Hungary, Faculty of Pharmaceutical Sciences, Matsuyama University, Matsuyama-shi, Japan |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |